-
Article
High-frequency aflibercept injections in persistent neovascular age-related macular degeneration
To report the 1-year outcomes of every-4-weeks (Q4W) as-needed aflibercept treatment in resistant neovascular age-related macular degeneration (nAMD) patients who had been treated and failed prior bevacizumab ...
-
Article
Erratum to: High-frequency aflibercept injections in persistent neovascular age-related macular degeneration
-
Article
Comparison of conventional color fundus photography and multicolor imaging in choroidal or retinal lesions
Our purpose was to compare the characteristics of the retinal and choroidal lesions including choroidal nevus, choroidal melanoma and congenital hypertrophy of the retina pigment epithelium using conventional ...
-
Article
Bevacizumab dosing every 2 weeks for neovascular age-related macular degeneration refractory to monthly dosing
To evaluate intravitreal bevacizumab every 2 weeks (biweekly) in refractory neovascular age-related macular degeneration (nAMD).
-
Article
Durability of every-8-week aflibercept maintenance therapy in treatment-experienced neovascular age-related macular degeneration
To determine the proportion of treatment-experienced eyes with exudative age-related macular degeneration successfully treated with every-4-week aflibercept that can be kept dry on fixed every-8-week afliberce...
-
Article
Characterization of deeply embedded corneal foreign bodies with anterior segment optical coherence tomography
The purpose of the study was to describe findings demonstrated by anterior segment spectral domain optical coherence tomography (AS-OCT) in various types of deeply embedded corneal foreign bodies.